Evaluation of chromane derivatives: Promising privileged scaffolds for lead discovery within Alzheimer’s disease-Reference-Cited by-同舟云学术

Evaluation of chromane derivatives: Promising privileged scaffolds for lead discovery within Alzheimer’s disease

Published:2022-08 Issue: Volume:68 Page:116807
ISSN:0968-0896
Container-title:Bioorganic & Medicinal Chemistry
language:en
Short-container-title:Bioorganic & Medicinal Chemistry

Author:

Moutayakine Amina,Marques Carolina,López Óscar,Bagetta Donatella,Leitzbach Luisa,Hagenow Stefanie,Carreiro Elisabete P.,Stark Holger,Alcaro Stefano,Fernández-Bolaños José G.,Burke Anthony J.

Funder

Junta de Andalucía

European Cooperation in Science and Technology

Fundação para a Ciência e a Tecnologia

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference42 articles.

1. (a) WHO, Dementia, 2020. https://www.who.int/news-room/fact-sheets/detail/dementia. Accessed 30 December 2021. (b) Patterson C. World Alzheimer Report 2018: The state of the art of dementia research: New frontiers; Sep 2018. (c) Gauthier S, Rosa-Neto P, Morais J.A, Webster C. World Alzheimer Report 2021: Journey through the diagnosis of dementia. London, England: Alzheimer’s Disease International; 2021.

2. Anti-Alzheimer’s Disease Activity of Bromophenols from a Red Alga, Symphyocladia latiuscula (Harvey) Yamada;Paudel;ACS Omega,2019

3. Polypharmacology by Design: A Medicinal Chemist's Perspective on Multitargeting Compounds;Proschak;J Med Chem.,2019

4. N-1,2,3-triazole-isatin derivatives for cholinesterase and β-amyloid aggregation inhibition: A comprehensive bioassay study;Marques;Bioorg Chem.,2020

5. Design, Synthesis and Bioassays of 3-Substituted-3-Hydroxyoxindoles for Cholinesterase Inhibition;Totobenazara;Chem Select.,2016

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. N-Substituted 3-Aminooxindoles and N-Propargyl Derivatives: Potential Biological Activities against Alzheimer’s Disease;Results in Chemistry;2023-12

2. Investigation of the enantioselectivity of acetylcholinesterase and butyrylcholinesterase upon inhibition by tacrine-iminosugar heterodimers;Journal of Enzyme Inhibition and Medicinal Chemistry;2022-12-01

3. Design, Synthesis, and Biological Evaluation of Novel Chromanone Derivatives as Multifunctional Agents for the Treatment of Alzheimer’s Disease;ACS Chemical Neuroscience;2022-11-16

4. Carbohydrate-derived bicyclic selenazolines as new dual inhibitors (cholinesterases/OGA) against Alzheimer’s disease;Bioorganic Chemistry;2022-10

5. A hybrid of 1-deoxynojirimycin and benzotriazole induces preferential inhibition of butyrylcholinesterase (BuChE) over acetylcholinesterase (AChE);Journal of Enzyme Inhibition and Medicinal Chemistry;2022-09-06